Although there was a small improvement at the later follow-ups at 12 and 24 months, its size was small and did not reach statistical significance ( Table 3 ).
← all excerpts
Neovascular Age-Related Macular Degeneration in the Very Old (≥90 Years): Epidemiology, Adherence to Treatment, and Comparison of Efficacy.
1
—
—